PT1611108E - Processo para a preparação de telmisartan - Google Patents

Processo para a preparação de telmisartan Download PDF

Info

Publication number
PT1611108E
PT1611108E PT04739071T PT04739071T PT1611108E PT 1611108 E PT1611108 E PT 1611108E PT 04739071 T PT04739071 T PT 04739071T PT 04739071 T PT04739071 T PT 04739071T PT 1611108 E PT1611108 E PT 1611108E
Authority
PT
Portugal
Prior art keywords
telmisartan
production
Prior art date
Application number
PT04739071T
Other languages
English (en)
Inventor
Norbert Hauel
Dach Rolf
Helmut Heitger
Oliver Meyer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33016100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1611108(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT1611108E publication Critical patent/PT1611108E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
PT04739071T 2003-03-31 2004-03-26 Processo para a preparação de telmisartan PT1611108E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10314702A DE10314702A1 (de) 2003-03-31 2003-03-31 Verfahren zur Herstellung von Telmisartan

Publications (1)

Publication Number Publication Date
PT1611108E true PT1611108E (pt) 2011-09-01

Family

ID=33016100

Family Applications (2)

Application Number Title Priority Date Filing Date
PT101925618T PT2322511E (pt) 2003-03-31 2004-03-26 Processo para a preparação de telmisartan
PT04739071T PT1611108E (pt) 2003-03-31 2004-03-26 Processo para a preparação de telmisartan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT101925618T PT2322511E (pt) 2003-03-31 2004-03-26 Processo para a preparação de telmisartan

Country Status (26)

Country Link
US (2) US7193089B2 (pt)
EP (2) EP2322511B1 (pt)
JP (1) JP5160740B2 (pt)
KR (1) KR101096499B1 (pt)
CN (1) CN100418953C (pt)
AR (2) AR043794A1 (pt)
AT (1) ATE515500T1 (pt)
AU (1) AU2004226239B2 (pt)
BR (1) BRPI0408861A (pt)
CA (1) CA2520714C (pt)
CL (1) CL2004000687A1 (pt)
CY (2) CY1112020T1 (pt)
DE (1) DE10314702A1 (pt)
DK (2) DK2322511T3 (pt)
ES (2) ES2369081T3 (pt)
IL (1) IL171145A (pt)
MX (1) MXPA05009529A (pt)
NZ (1) NZ543244A (pt)
PE (1) PE20050390A1 (pt)
PL (2) PL1611108T3 (pt)
PT (2) PT2322511E (pt)
RU (1) RU2430092C2 (pt)
SI (2) SI1611108T1 (pt)
TW (1) TWI335916B (pt)
UY (1) UY28246A1 (pt)
WO (1) WO2004087676A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1699765A1 (en) * 2004-10-15 2006-09-13 Teva Pharmaceutical Industries Ltd Process for preparing telmisartan
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
US7968727B2 (en) 2005-04-01 2011-06-28 Lek Pharmaceuticals, D.D. Synthesis of 4-bromomethyl-2′-formylbiphenyl and 4-bromomethyl-2′-hydroxymethylbiphenyl and its use in preparation of angiotensin II antagonists
ITMI20050801A1 (it) * 2005-05-03 2006-11-04 Dipharma Spa Procedimento per la preparazione di telmisartan
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US20060264491A1 (en) * 2006-06-08 2006-11-23 Chemagis Ltd. Telmisartan production process
CN101172968B (zh) * 2006-11-01 2010-05-12 浙江天宇药业有限公司 2-正丙基-4甲基-6-(甲基苯并咪唑-2-基)苯并咪唑盐及其制备方法
CN101743228B (zh) * 2007-07-03 2014-01-29 新梅斯托克尔卡托瓦纳兹德拉韦尔公司 替米沙坦的制备方法
CZ302272B6 (cs) 2007-07-09 2011-01-19 Zentiva, A. S. Zpusob výroby 4´-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-karboxylové kyseliny (telmisartanu)
WO2009116089A2 (en) * 2008-03-14 2009-09-24 Ipca Laboratories Limited Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
EP2103609A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
US8410285B2 (en) 2008-03-20 2013-04-02 Lek Pharmaceuticals D.D. 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP2103588A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP2123648A1 (en) 2008-05-20 2009-11-25 Chemo Ibérica, S.A. A process for the preparation of Telmisartan.
EP2149566A1 (en) 2008-07-15 2010-02-03 Chemo Ibérica, S.A. A process for the preparation of telmisartan
PL2443094T3 (pl) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Sposób wytwarzania telmisartanu
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2305650A1 (en) 2009-09-21 2011-04-06 Chemo Ibérica, S.A. Novel process for the preparation of telmisartan
EA025946B1 (ru) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
CN102267949A (zh) * 2011-06-14 2011-12-07 张长利 替米沙坦制备新工艺
WO2014027280A1 (en) 2012-08-14 2014-02-20 U Amarnath Amarnath One pot process for the preparation of telmisartan
CN103787982A (zh) * 2012-10-31 2014-05-14 上海特化医药科技有限公司 制备替米沙坦的方法及其中间体
CN104557724B (zh) * 2014-11-17 2017-01-11 江苏中邦制药有限公司 替米沙坦不定形晶型及其制备方法
CN105130905B (zh) * 2015-09-17 2017-09-08 浙江金立源药业有限公司 一种替米沙坦的合成方法
CN109912512B (zh) * 2017-12-13 2023-05-30 上海科胜药物研发有限公司 一种新的替米沙坦杂质化合物及其制备方法和用途
CN112251770B (zh) * 2020-10-14 2021-07-27 湖南大学 一种抗高血压药替米沙坦中间体电化学制备新方法
CN113307775B (zh) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 一种替米沙坦的制备方法
WO2023204729A1 (ru) * 2022-04-19 2023-10-26 Общество с ограниченной ответственностью "Гелеспон" Фармацевтические композиции на основе новой субстанции 4-[2-(1н-имидазол-4-ил)-этилкарбамоил]-бутановой кислоты и способ получения субстанции

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
DE4103492A1 (de) * 1991-02-06 1992-10-08 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19901921C2 (de) * 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
US6358986B1 (en) 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan

Also Published As

Publication number Publication date
ES2432647T3 (es) 2013-12-04
CN100418953C (zh) 2008-09-17
IL171145A (en) 2010-12-30
RU2005133479A (ru) 2006-07-27
KR101096499B1 (ko) 2011-12-20
US7193089B2 (en) 2007-03-20
CY1112020T1 (el) 2015-11-04
AU2004226239A1 (en) 2004-10-14
US20040236113A1 (en) 2004-11-25
US20130137878A1 (en) 2013-05-30
MXPA05009529A (es) 2005-10-19
DE10314702A1 (de) 2004-10-21
ATE515500T1 (de) 2011-07-15
KR20050118699A (ko) 2005-12-19
CA2520714A1 (en) 2004-10-14
JP2006521289A (ja) 2006-09-21
CN1768044A (zh) 2006-05-03
DK2322511T3 (da) 2013-10-28
TWI335916B (en) 2011-01-11
AU2004226239B2 (en) 2011-04-21
TW200504055A (en) 2005-02-01
PE20050390A1 (es) 2005-06-23
UY28246A1 (es) 2004-11-08
EP2322511B1 (de) 2013-07-31
ES2369081T3 (es) 2011-11-25
EP1611108B1 (de) 2011-07-06
CL2004000687A1 (es) 2005-02-04
NZ543244A (en) 2010-02-26
US8993778B2 (en) 2015-03-31
WO2004087676A1 (de) 2004-10-14
AR043794A1 (es) 2005-08-10
EP1611108A1 (de) 2006-01-04
PL2322511T3 (pl) 2014-01-31
JP5160740B2 (ja) 2013-03-13
CA2520714C (en) 2012-05-15
CY1115156T1 (el) 2016-12-14
DK1611108T3 (da) 2011-10-10
PT2322511E (pt) 2013-08-29
AR087209A2 (es) 2014-02-26
SI1611108T1 (sl) 2011-10-28
EP2322511A1 (de) 2011-05-18
BRPI0408861A (pt) 2006-04-11
RU2430092C2 (ru) 2011-09-27
PL1611108T3 (pl) 2011-12-30
SI2322511T1 (sl) 2013-10-30

Similar Documents

Publication Publication Date Title
IL171145A (en) Method for the production of telmisartan
HK1107821A1 (en) Method for the production of dihydropteridinones
ZA200605864B (en) Method for the production of methionine
IL175148A0 (en) Method for the production of fluoromethyl-substituted heterocycles
HK1079771A1 (en) Process for the manufacture of valsartan
PT1748990E (pt) Processo para a preparação de telmisartan
IL169352A0 (en) Improved method for the production of vitamin b12
PL377943A1 (pl) Sposób wytwarzania benzofenonów
GB2400107B (en) Method for the production of polymeric material
GB0312966D0 (en) Process for the production of olefins
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
AU2003219524A1 (en) Method for the production of elongated elements for jewels
PL1670841T3 (pl) Sposób wytwarzania mieszanin polioli
GEU20041064U (en) Method for production of Matsoni
AU2003229622A8 (en) Method for the production of phenyl propyl alcohols
AU2003233239A1 (en) Method for the production of polymethylenepolysulfides
AU2003226696A8 (en) Improved method for the production of vitamin b12
ZA200700282B (en) Method for the production of dihydropteridinones
GB0312093D0 (en) Process for the production of olefins
GB0312968D0 (en) Process for the production of olefins
GB0323640D0 (en) Method of production
IL170747A0 (en) Process for the production of imidazopyridin-8-one derivatives
SI1572613T1 (sl) Postopek za proizvodnjo benzofenonov
ZA200510102B (en) New process for the production of melagatran
GB0312970D0 (en) Process for the production of olefins